Acute Coronary Syndrome Developed after Vincristine Administration

被引：0
|
作者：
Ozturk, Serkan [1 ]
Baltaci, Davut [2 ]
Ayhan, Selim [1 ]
Yazici, Mehmet [1 ]
Saritas, Ayhan [3 ]
机构：
[1] Abant Izzet Baysal Univ, Fac Med, Dept Cardiol, Bolu, Turkey
[2] Duzce Univ, Fac Med, Dept Family Med, Duzce, Turkey
[3] Duzce Univ, Fac Med, Dept Emergency Med, Duzce, Turkey
来源：
TURKISH JOURNAL OF EMERGENCY MEDICINE | 2011年 / 11卷 / 04期
关键词：
Atrio-ventricular block; doxorubicin; myocardial infarction; vincristine;
D O I：
10.5505/1304.7361.2011.68725
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
Vincristine and doxorubicin are among the most effective chemotherapeutic agents used in the treatment of malignancies in combination per protocols. However, these chemotherapeutic agents possess great risk for development of cardiotoxicity. The most common manifestations of cardiotoxicity due to use of those chemotherapeutic agents are arrhythmias, systolic dysfunction, cardiomyopathy, pericardial injury and myocardial ischemia. We present a case of acute coronary syndrome with complete atrio-ventricular (AV) block, developed after vincristine and doxorubicin chemotherapy in a patient with multiple myeloma and no cardiac history.
引用
收藏
页码：171 / 173
页数：3
相关论文
共 50 条
  • [41] Cardiac Rehabilitation After Hospitalization for Acute Coronary Syndrome
    Ravi Thakker
    Mahin Khan
    Bashar Al-Hemyari
    Current Cardiology Reports, 2023, 25 : 1699 - 1703
  • [42] Failure of secondary prevention after acute coronary syndrome
    Bouamaied, N.
    Monassier, J. P.
    DIABETES & METABOLISM, 2007, 33 : S83 - S83
  • [43] Acute compartment syndrome after transradial coronary angioplasty
    Lin, YJ
    Chu, CC
    Tsai, CW
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2004, 97 (02) : 311 - 311
  • [44] Optimal management of patients after acute coronary syndrome
    Panattoni, Germana
    Monzo, Luca
    Gugliotta, Maria
    Proietti, Giulia
    Tatangelo, Mario
    Jacomelli, Ilaria
    Zimbardo, Giuseppe
    Meringolo, Federica
    Fedele, Elisa
    Calo, Leonardo
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25 : C84 - C89
  • [45] Statins after acute coronary syndrome: a missed opportunity
    Roth, Gregory A.
    HEART, 2014, 100 (10) : 752 - 753
  • [46] Early treatment of statins after acute coronary syndrome?
    Hamm, Christian W.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2011, 136 (39) : 1941 - 1941
  • [47] β-blocker dosage and outcomes after acute coronary syndrome
    Allen, Jason E.
    Knight, Stacey
    McCubrey, Raymond O.
    Bair, Tami
    Muhlestein, Joseph Brent
    Goldberger, Jeffrey J.
    Anderson, Jeffrey L.
    AMERICAN HEART JOURNAL, 2017, 184 : 26 - 36
  • [48] To be or not to be referred for cardiac rehabilitation after acute coronary syndrome
    Ferreira, Jorge
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2017, 36 (03) : 177 - 178
  • [49] Admission glycaemia and outcome after acute coronary syndrome
    Petursson, P.
    Herlitz, J.
    Caidahl, K.
    Gudbjornsdottir, S.
    Karlsson, T.
    Perm, E.
    Sjoland, H.
    Hartford, M.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 116 (03) : 315 - 320
  • [50] Ischemic Stroke Risk After Acute Coronary Syndrome
    Yaghi, Shadi
    Pilot, Markeith
    Song, Christopher
    Blum, Christina A.
    Yakhkind, Aleksandra
    Silver, Brian
    Furie, Karen L.
    Elkind, Mitchell S. V.
    Sherzai, Dean
    Sherzai, Ayesha Z.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (07):
12345